Liting Zhu
-
- Spine and Intervertebral Disc Pathology 6
- Lymphoma Diagnosis and Treatment 6
- Oncology top 2%
- Cancer Diagnosis and Treatment 7
- Cancer Treatment and Pharmacology 5
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 3
- Neurology top 10%
- CNS Lymphoma Diagnosis and Treatment 3
- Dermatology top 10%
-
- Management of metastatic bone disease 13
-
- Pain Management and Opioid Use 3
- Co-authors
- Michael CrumpAnnette E. HayJohn KuruvillaSattva S. NeelapuUmar FarooqÉric Van Den NesteSami BoussettaChristian Gisselbrecht
- Journals
- Journal of Clinical Oncology (7 papers)Blood (1 paper)JNCI Journal of the National Cancer Institute (2 papers)
- Partner nations
- CanadaUnited StatesChina
In The Last Decade
Liting Zhu
44 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 96
- Pathology and Forensic Medicine 749
- Oncology 1.1k
- Genetics 172
- Neurology 127
- Dermatology 72
Countries citing papers authored by Liting Zhu
This map shows the geographic impact of Liting Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liting Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liting Zhu more than expected).
Fields of papers citing papers by Liting Zhu
This network shows the impact of papers produced by Liting Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liting Zhu. The network helps show where Liting Zhu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Liting Zhu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 7 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 1 | |
| 4 | 2022 | 1 | |
| 5 | 2021 | 10 | |
| 6 | 2018 | 3 | |
| 7 | Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 studybreakdown → | 2017 | 1042 |
| 8 | 2017 | 11 | |
| 9 | 2017 | 11 | |
| 10 | 2017 | 3 | |
| 11 | 2017 | 32 | |
| 12 | 2017 | 5 | |
| 13 | 2016 | 15 | |
| 14 | 2016 | 15 | |
| 15 | 2016 | 4 | |
| 16 | 2016 | 18 | |
| 17 | 2015 | 15 | |
| 18 | 2015 | 6 | |
| 19 | 2014 | 6 | |
| 20 | 2011 | 1 |
About Liting Zhu
Liting Zhu is a scholar working on Oncology, Behavioral Neuroscience and Pathology and Forensic Medicine, having authored 47 papers that have together received 1.5k indexed citations. Recurring topics across this work include Management of metastatic bone disease (13 papers), Cancer Diagnosis and Treatment (7 papers), Spine and Intervertebral Disc Pathology (6 papers), Lymphoma Diagnosis and Treatment (6 papers), Cancer Treatment and Pharmacology (5 papers), Pain Management and Opioid Use (3 papers), Chronic Lymphocytic Leukemia Research (3 papers) and CNS Lymphoma Diagnosis and Treatment (3 papers). The work is most often cited by research in Pathology and Forensic Medicine (749 citations), Oncology (1.1k citations) and Genetics (172 citations). Liting Zhu has collaborated with scholars based in Canada, United States and China. Frequent co-authors include Michael Crump, Annette E. Hay, John Kuruvilla, Sattva S. Neelapu, Umar Farooq, Éric Van Den Neste, Sami Boussetta, Christian Gisselbrecht, Matthew J. Maurer and James R. Cerhan. Their work appears in journals such as Journal of Clinical Oncology, Blood and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.